- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
ACVR2A is a receptor protein that belongs to the TGF-beta superfamily, which is known for its role in controlling cell growth, differentiation, and development. Studies have shown that mutations in the ACVR2A gene can lead to a variety of health conditions, including certain types of cancer and developmental disorders. One of the most intriguing aspects of ACVR2A is its potential as a therapeutic target. By developing drugs that can modulate the activity of ACVR2A, researchers may be able to treat a range of diseases, from cancer to muscular dystrophy. Recent studies have even suggested that targeting ACVR2A could help improve outcomes for patients with certain types of cancer.
The stated application concentrations are suggested starting points. Titration of the ACVR2A antibody may be required due to differences in protocols and secondary/substrate sensitivity.
A portion of amino acids 2-29 from the human protein was used as the immunogen for the ACVR2A antibody.
Aliquot the ACVR2A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.